RAB4A acts as a negative feedback regulator of extracellular vesicle secretion during TGF ‐β signaling
The FEBS Journal · 2026
DOI: 10.1111/febs.70520 ↗At a glance
Journal article in The FEBS Journal, 2026. Written by Dorival Mendes Rodrigues-Junior and 5 co-authors. Institution: Department of Medical Biochemistry and Microbiology, Science for Life Laboratory, Box 582, Biomedical Center, Uppsala University, Sweden. Major MEDLINE topics: rab4 GTP-Binding Proteins, Transforming Growth Factor beta, Extracellular Vesicles. Cited 1 times so far (Crossref); 59 references. The full text is freely available (open access, CC BY 4.0). Funded by: Stiftelsen Lars Hiertas Minne, The Sigurs and Elsa Golje Memorial Foundation, Vetenskapsrådet.
Abstract (original language)
Extracellular vesicles (EVs) secreted by cancer cells actively modulate the tumor microenvironment, thereby promoting cancer progression. Transforming growth factor‐β (TGF‐β) signaling has been implicated in the regulation of EV biogenesis, yet the molecular mechanisms underlying this process have only recently begun to emerge. In this study, we investigated TGF‐β‐responsive mediators that regulate EV release in lung, breast, and ovarian carcinoma cells by modulating the expression and activity of genes associated with EV biogenesis, including components of the ESCRT machinery, tetraspanins, and Rab GTPases. We found that TGF‐β selectively enhances the mRNA expression of PDCD6IP ( ALIX ), CD81 , ARF6 , and RAB4A in a cell type–specific manner. R‐SMAD silencing had clear negative effects on the regulation of ALIX or RAB4A , whereas AKT kinase inhibition suppressed the induction of ALIX and CD81 . Additionally, TGF‐β stimulation increased ALIX S‐palmitoylation, consistent with enhanced ALIX–TSG101 complex formation on vesicular membranes. However, knockdown of ALIX or CD81 did not impair TGF‐β‐induced EV secretion. On the contrary, TGF‐β‐induced upregulation of RAB4A expression is functionally unique because RAB4A facilitates fast endosomal recycling, a process that limits EV release. Accordingly, silencing RAB4A significantly increased the fusion of multivesicular bodies with the plasma membrane followed by EV secretion, suggesting that TGF‐β‐induced RAB4A acts as a negative feedback regulator of EV release. Our findings reveal a novel mechanism by which RAB4A modulates TGF‐β‐driven EV production by cancer cells.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Medical Biochemistry and Microbiology, Science for Life Laboratory, Box 582, Biomedical Center, Uppsala University, Sweden.
- Department of Biochemistry, University of Yamanashi, Japan.
- Department of Cell Biology, Neurobiology and Biophysics, Utrecht University, The Netherlands.
- Department of Medical Cell Biology, Uppsala University, Sweden.
ORCID profiles: Dorival Mendes Rodrigues-Junior, Aristidis Moustakas
Funding
- Stiftelsen Lars Hiertas Minne
- The Sigurs and Elsa Golje Memorial Foundation
- Vetenskapsrådet
- Cancerfonden
- Stiftelsen Längmanska Kulturfonden
- O.E. och Edla Johanssons Vetenskapliga Stiftelsen
Cite
APA
Rodrigues-Junior, D. M., Doumani, M. A., Fu, H., van den Bor, J., Idevall-Hagren, O., & Moustakas, A. (2026). RAB4A acts as a negative feedback regulator of extracellular vesicle secretion during TGF ‐β signaling. The FEBS Journal. https://doi.org/10.1111/febs.70520
Vancouver
Rodrigues-Junior DM, Doumani MA, Fu H, van den Bor J, Idevall-Hagren O, Moustakas A. RAB4A acts as a negative feedback regulator of extracellular vesicle secretion during TGF ‐β signaling. The FEBS Journal. 2026. doi:10.1111/febs.70520
BibTeX
@article{RodriguesJunior2026,
author = {Rodrigues-Junior, Dorival Mendes and Doumani, Maria Anastasia and Fu, Hao and van den Bor, Jelle and Idevall-Hagren, Olof and Moustakas, Aristidis},
title = {RAB4A acts as a negative feedback regulator of extracellular vesicle secretion during TGF ‐β signaling},
journal = {The FEBS Journal},
year = {2026},
doi = {10.1111/febs.70520}
}
EUVIMED